NCT01125995View on ClinicalTrials.gov

Early Versus Late Concurrent Chemoradiation for Limited Stage Small-cell Lung Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

222

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

July 31, 2011

Study Completion Date

May 31, 2013

Conditions
Small Cell Lung Cancer
Interventions
RADIATION

early CCRT

"1. patients will be received with 4 cycles of etoposide 100mg/m2 D1-3 \& Cisplatin 70mg/m2 D1.~2. radiotherapy start from day 1 of 1st chemotherapy cycle and complete 5250cGy/25fraction (daily one fraction, 210cGy)."

RADIATION

late CCRT

"1. patients will be received with 4 cycles of etoposide 100mg/m2 D1-3 \& Cisplatin 70mg/m2 D1.~2. radiotherapy start from day 1 of the third cycle of EP chemotherapy and complete 5250cGy/25fraction (daily one fraction, 210cGy)."

Trial Locations (2)

135-710

Keunchil Park, Seoul

Unknown

Asan Medican Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT01125995 - Early Versus Late Concurrent Chemoradiation for Limited Stage Small-cell Lung Cancer | Biotech Hunter | Biotech Hunter